Next Article in Journal
Redox-Responsive Nanocarrier for Controlled Release of Drugs in Inflammatory Skin Diseases
Next Article in Special Issue
Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography
Previous Article in Journal
Nasal Gel Loaded with Amphotericin Nanotransferosomes as Antifungal Treatment for Fungal Sinusitis
Previous Article in Special Issue
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Review

Therapeutic Ophthalmic Lenses: A Review

1
Centro de Química Estrutural, Instituto Superior Técnico, University of Lisbon, Av. Rovisco Pais, 1049-001 Lisbon, Portugal
2
Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal
*
Author to whom correspondence should be addressed.
Pharmaceutics 2021, 13(1), 36; https://doi.org/10.3390/pharmaceutics13010036
Received: 12 November 2020 / Revised: 9 December 2020 / Accepted: 17 December 2020 / Published: 28 December 2020
(This article belongs to the Special Issue Recent Advances in Ophthalmic Drug Delivery)
An increasing incidence of eye diseases has been registered in the last decades in developed countries due to the ageing of population, changes in lifestyle, environmental factors, and the presence of concomitant medical conditions. The increase of public awareness on ocular conditions leads to an early diagnosis and treatment, as well as an increased demand for more effective and minimally invasive solutions for the treatment of both the anterior and posterior segments of the eye. Despite being the most common route of ophthalmic drug administration, eye drops are associated with compliance issues, drug wastage by lacrimation, and low bioavailability due to the ocular barriers. In order to overcome these problems, the design of drug-eluting ophthalmic lenses constitutes a non-invasive and patient-friendly approach for the sustained drug delivery to the eye. Several examples of therapeutic contact lenses and intraocular lenses have been developed, by means of different strategies of drug loading, leading to promising results. This review aims to report the recent advances in the development of therapeutic ophthalmic lenses for the treatment and/or prophylaxis of eye pathologies (i.e., glaucoma, cataract, corneal diseases, or posterior segment diseases) and it gives an overview of the future perspectives and challenges in the field. View Full-Text
Keywords: therapeutic contact lenses; therapeutic intraocular lenses; eye diseases; glaucoma; cataract; corneal diseases; posterior segment of the eye diseases therapeutic contact lenses; therapeutic intraocular lenses; eye diseases; glaucoma; cataract; corneal diseases; posterior segment of the eye diseases
Show Figures

Graphical abstract

MDPI and ACS Style

Toffoletto, N.; Saramago, B.; Serro, A.P. Therapeutic Ophthalmic Lenses: A Review. Pharmaceutics 2021, 13, 36. https://doi.org/10.3390/pharmaceutics13010036

AMA Style

Toffoletto N, Saramago B, Serro AP. Therapeutic Ophthalmic Lenses: A Review. Pharmaceutics. 2021; 13(1):36. https://doi.org/10.3390/pharmaceutics13010036

Chicago/Turabian Style

Toffoletto, Nadia, Benilde Saramago, and Ana P. Serro 2021. "Therapeutic Ophthalmic Lenses: A Review" Pharmaceutics 13, no. 1: 36. https://doi.org/10.3390/pharmaceutics13010036

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop